Brasada Capital Management LP Acquires Shares of 16,918 Ventas, Inc. $VTR

Posted by Stanley Muller on Aug 28th, 2026

Brasada Capital Management LP bought a new position in Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 16,918 shares of the real estate investment trust’s stock, valued at approximately $1,502,000.

Other hedge funds have also recently made changes to their positions in the company. NewEdge Advisors LLC lifted its position in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after buying an additional 7,097 shares during the last quarter. Empowered Funds LLC increased its holdings in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after acquiring an additional 536 shares during the last quarter. Woodline Partners LP increased its holdings in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after acquiring an additional 11,739 shares during the last quarter. Focus Partners Wealth raised its stake in Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL bought a new stake in Ventas in the 2nd quarter valued at about $805,000. 94.18% of the stock is currently owned by institutional investors.

Insider Activity at Ventas

In other news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.53% of the company’s stock.

Ventas Stock Down 0.6%

Shares of NYSE VTR opened at $92.89 on Friday. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The business has a 50-day simple moving average of $92.22 and a two-hundred day simple moving average of $87.54. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company has a market cap of $47.65 billion, a P/E ratio of 172.02, a P/E/G ratio of 2.15 and a beta of 0.69.

Ventas (NYSE:VTR – Get Free Report) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm earned $0.87 EPS. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. Research analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on VTR. Royal Bank Of Canada increased their target price on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Scotiabank lowered their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Citigroup upped their price target on shares of Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. UBS Group upped their price target on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Finally, Wells Fargo & Company lifted their price objective on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $98.00.

Get Our Latest Analysis on Ventas

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.